Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.48%
#2 Ocean Protocol Ocean Protocol +21.53%
#3 Geodnet Geodnet +15.00%
#4 Audiera Audiera +11.80%
#5 Cysic Cysic +8.78%
#6 KUB Coin KUB Coin +8.63%
#7 Arowana Arowana +7.85%
#8 DexNet DexNet +7.78%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.66%
#10 Rollbit Coin Rollbit Coin +6.27%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc.

MPLT
Rankning i aktier #32258
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm... MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease. Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.
Aktiekurs
$13.43
Senast synkroniserad: 2026-07-31
Marknadsvärde
$10.60M
Förändring (1 dag)
-4.26%
Förändring (1 år)
-
Land
US
Handel MapLight Therapeutics, Inc. (MPLT)

Kategori

Healthcare
Aktiekurshistorik för MapLight Therapeutics, Inc. (MPLT)
Högsta slutkurs: $31.59 den 2026-07-01

Lägsta slutkurs: $17.39 den 2025-10-01
Aktiekurshistorik för MapLight Therapeutics, Inc. från 2025 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 22.89%
2025 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.17 -36.90%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.06K -6.61%
KR